DURABILITY OF APREMILAST RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: LONG-TERM (208-WEEK) RESULTS FROM THE PALACE 1 TRIAL
Kavanaugh A, Gladman DD, Gomez-Reino JJ, Hall S, Lespessailles E, Mease PJ, Schett G, Mcilraith M, Delev N, Paris M, Teng L, Wollenhaupt J (2017)
Publication Type: Conference contribution
Publication year: 2017
Journal
Book Volume: 76
Pages Range: 936-937
Authors with CRIS profile
Involved external institutions
Celgene Corporation
United States (USA) (US)
University of Toronto
Canada (CA)
University of California, San Diego
United States (USA) (US)
Complejo Hospitalario Universitario de Santiago de Compostela
Spain (ES)
Schön Klinik Hamburg Eilbek
Germany (DE)
University of Orléans / Université d'Orléans
France (FR)
Monash University
Australia (AU)
Swedish Medical Center
United States (USA) (US)
United States (USA) (US)
University of Toronto
Canada (CA)
University of California, San Diego
United States (USA) (US)
Complejo Hospitalario Universitario de Santiago de Compostela
Spain (ES)
Schön Klinik Hamburg Eilbek
Germany (DE)
University of Orléans / Université d'Orléans
France (FR)
Monash University
Australia (AU)
Swedish Medical Center
United States (USA) (US)
How to cite
APA:
Kavanaugh, A., Gladman, D.D., Gomez-Reino, J.J., Hall, S., Lespessailles, E., Mease, P.J.,... Wollenhaupt, J. (2017). DURABILITY OF APREMILAST RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: LONG-TERM (208-WEEK) RESULTS FROM THE PALACE 1 TRIAL. (pp. 936-937).
MLA:
Kavanaugh, A., et al. "DURABILITY OF APREMILAST RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: LONG-TERM (208-WEEK) RESULTS FROM THE PALACE 1 TRIAL." 2017. 936-937.
BibTeX: Download